Viewing Study NCT04590560


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2025-12-26 @ 3:27 AM
Study NCT ID: NCT04590560
Status: RECRUITING
Last Update Posted: 2024-12-09
First Post: 2020-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module